open access

Vol 4, No 6 (2015)
Original articles (submitted)
Published online: 2016-02-22
Get Citation

Quality of life among patients with type 2 diabetes after insulin therapy introduction: A prospective study

Marta Dudzińska, Jerzy S. Tarach, Agnieszka Zwolak, Joanna Malicka, Mariusz Kowalczyk, Joanna Świrska, Jadwiga Daniluk
DOI: 10.5603/DK.2015.0030
·
Clinical Diabetology 2015;4(6):226-231.

open access

Vol 4, No 6 (2015)
Original articles (submitted)
Published online: 2016-02-22

Abstract

Introduction. In case of many patients with type 2 diabetes, despite deterioration of glycaemic control the moment of intensification of treatment is delayed because of barriers to initiating insulin therapy. Aim. The aim of the study was an evaluation of changes on Health Related Quality of Life (HRQoL) after intensification of the treatment among group of type 2 diabetes patients.

Methods. The study involved 52 patients, treated so far by oral anti-diabetic drugs (OAD), for whom insulin was introduced. This group was exposed to 8 (± 1.5) months long observation. HRQoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R.

Results. After prospective observation, patients described significant improvement in QoL (EQ-VAS, DSC-R). DQL-BCI score remained unchanged, although detailed analysis showed improvement in treatment satisfaction, improvement in the level of knowledge about diabetes and increase in diabetes-related pain.

Conclusions. Our study confirms the improvement in HRQoL after insulin therapy introduction. The results should encourage to early implementation of intensification of treatment.  

Abstract

Introduction. In case of many patients with type 2 diabetes, despite deterioration of glycaemic control the moment of intensification of treatment is delayed because of barriers to initiating insulin therapy. Aim. The aim of the study was an evaluation of changes on Health Related Quality of Life (HRQoL) after intensification of the treatment among group of type 2 diabetes patients.

Methods. The study involved 52 patients, treated so far by oral anti-diabetic drugs (OAD), for whom insulin was introduced. This group was exposed to 8 (± 1.5) months long observation. HRQoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R.

Results. After prospective observation, patients described significant improvement in QoL (EQ-VAS, DSC-R). DQL-BCI score remained unchanged, although detailed analysis showed improvement in treatment satisfaction, improvement in the level of knowledge about diabetes and increase in diabetes-related pain.

Conclusions. Our study confirms the improvement in HRQoL after insulin therapy introduction. The results should encourage to early implementation of intensification of treatment.  

Get Citation

Keywords

type 2 diabetes, insulin therapy, Health Related Quality of Life, education, treatment satisfaction

About this article
Title

Quality of life among patients with type 2 diabetes after insulin therapy introduction: A prospective study

Journal

Clinical Diabetology

Issue

Vol 4, No 6 (2015)

Pages

226-231

Published online

2016-02-22

DOI

10.5603/DK.2015.0030

Bibliographic record

Clinical Diabetology 2015;4(6):226-231.

Keywords

type 2 diabetes
insulin therapy
Health Related Quality of Life
education
treatment satisfaction

Authors

Marta Dudzińska
Jerzy S. Tarach
Agnieszka Zwolak
Joanna Malicka
Mariusz Kowalczyk
Joanna Świrska
Jadwiga Daniluk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl